Comparative Non-Significant Risk MRI for Liver Fat Estimation

Overview

About this study

The purpose of this protocol is to further define two newly developed CSE-MRI methods (technical improvements of previously validated CSE-MRI methods) will be evaluated for conformance testing with the standard clinical method used at Mayo clinic (known as 3D-IDEAL-IQ) sequence.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

Adult patients who have clinical indication for limited liver MRI study that includes PDFF estimation.

Exclusion Criteria:

Contra-indications to MRI study.
Participants who are unable to undergo MR (claustrophobia, implanted device, etc.), pregnancy, obesity (> 400 lb).

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status	Contact
Rochester, Minn. Mayo Clinic principal investigator Sudhakar Venkatesh, M.D.	Closed-enrolling by invitation What is this? (?) "Close" Not open to everyone who meets the eligibility criteria, but only those invited to participate by the study team.	Contact information: Kathy Brown (507) 538-1321 brown.kathy@mayo.edu

Mayo Clinic Location

Status

Contact

Rochester, Minn.

Mayo Clinic principal investigator

Sudhakar Venkatesh, M.D.

Closed-enrolling by invitation

Contact information:

Kathy Brown

(507) 538-1321

brown.kathy@mayo.edu

More information

Publications

Publications are currently not available

Clinical Trials